Red Journal Oncology Scans - 2024
The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.
Category
- Thoracic
- SBRT
- Sarcoma
- Professional Development
- Gynecologic
- Breast
- Gastrointestinal
- Head and Neck
- Hematologic
Format
- Journal Activities
Credits
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Certificate of Attendance
Cost $299.00
Survival (Time-To-Event) Curve Names and Endpoints
This activity provides practitioners with the knowledge needed to interpret survival time analyses.
Category
- Health Policy/Informatics
Format
- Journal Activities
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $49.00
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
There are many ongoing advances in the multidisciplinary management of stage III NSCLC, in particular the advent of neoadjuvant immunotherapy in patients who are resectable.
Category
- Thoracic
- Immunotherapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.
Category
- Thoracic
- Oligometastatic
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Practical Radiation Oncology Program 2025
This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a strategic dialogue with the ASTRO CEO and a radiation oncology practice overview.
Category
- Thoracic
- Skin
- SBRT
- Sarcoma
- Gynecologic
- Breast
- Central Nervous System
- Gastrointestinal
- Genitourinary
- Head and Neck
Format
Credits
- 13.75 AMA PRA Category 1 Credit™
- 13.75 Certificate of Attendance
Cost $849.00
Moving Beyond the Basics: Implementation of a Radiopharmaceutical Therapy Program - RPT Workshop 2025
Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies.
Category
- Radiopharmaceutical Therapy
Format
- Sessions onDemand
Credits
- 4.50 AMA PRA Category 1 Credit™
- 4.50 Certificate of Attendance
Cost $379.00
Challenging Cases in Palliative Care: Novel Therapeutics, Radioresistant Histology and Treatment Delivery
There are many ongoing advances in clinical care in the context of palliative radiation therapy delivery, clinical decision-making on treatment options, and clinical workflows in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.
Category
- General RO
- Palliative Care
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Challenging Cases in the Management of Squamous Cell Carcinoma of the Skin
There is a general understanding and comfort in management of small, relatively well-defined SCC of the skin, even those that carry some high risk features (PNI, high DOI, high grade, etc).
Category
- Sarcoma
- Head and Neck
Format
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.
Category
- General RO
- Head and Neck
- Hematologic
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.
Category
- Patient Safety
- Hematologic
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00

Facebook
X
LinkedIn
Forward